TEL : 028-85121781
Set Homepage | Add Favorite     中文 | English
Home > Dynamic Center > Enterprise Dynamic >
Enterprise Dynamic
Thailand's Miska Bay Health Group and Nine Chapters Biotechnology announced a new collaboration to bring the next generation of cancer and anti-aging therapies to Thailand
Date:2024-09-18

Thailand's Miska Bay Health Group and Nine Chapters Biotechnology announced a new collaboration to bring the next generation of cancer and anti-aging therapies to Thailand

· This cooperation focuses on the patented chlorogenic acid products of Jiuzhang Biologics.

· Thailand Miska Bay Health Group obtained the import and distribution rights for these products in Thailand.

· The initial focus will be on Miska Bay Health Centres in Bangkok and Koh Samui, with a focus on cancer and anti-ageing treatments.

On September 7, 2024, Thailand Miska Bay Health Group (hereinafter referred to as "Miska Bay Group") and Sichuan Jiuzhang Biological Science and Technology Co.,Ltd (hereinafter referred to as " Jiuzhang Bio") has signed an exclusive cooperation agreement to license Miska The Gulf Group imports, distributes and uses Jiuzhang Bio's patented chlorogenic acid (CHA) products in Thailand.

Chlorogenic acid is a natural active ingredient that comes from plants and has been shown to strengthen the body's immune system, prevent disease and disease anti-aging effect. It is also widely used to fight chronic diseases such as cancer, effectively treating them by boosting the immune system cancer cells with few side effects.

Jiuzhang Bio's patented chlorogenic acid product is administered by injection and has been successfully completed in China against brain cancer in Phase I and Phase II clinical trials, the results were very positive.

微信截图_20240914154852.png

Executives from Jiuzhang Bio and Miska Bay Health Group attended the signing ceremony of the partnership agreement, from left: Mr. Zhang Jie Assistant Ms. Kiki Wang, Chief physician Professor Li Wenbin, Miska Bay Health Group Mr. David P Boehm, Chairman and Chief Executive Officer, Chairman and Chief Executive Officer of Jiuzhang Biology Mr. Jie Zhang and Dr. Parker Li, son of Professor Wenbin Li

The collaboration is expected to significantly drive revenue growth for Nine Chapters Bio and Miska Bay Group in the fourth quarter of 2024.

"Jiuzhang Bio's products have revolutionized the field of anti-aging and certain cancer treatments. Thailand Miska Bay Health Group is very pleased to partner with Jiuzhang Bio to provide these next-generation products to our patients. Nine Chapter Bio's products are based on plant extracts, which is a perfect fit with Miska Bay's natural health strategy." Said David Boehm, Chairman and CEO of Miska Bay Health Group.

"This is the first time of Jiuzhang Bio which has reached a distribution agreement with a foreign partner. We visited all three of Miska Bay's facilities in Thailand and were impressed with the forward-thinking medical care provided by their doctors and medical teams. We are confident that this cooperation agreement will lay the foundation for even closer cooperation between Bio Bio and the Miska Bay Group." Said Jie Zhang, chairman and chief executive officer of Jiuzhang Biology.

About Jiuzhang biotechnology (http://en.jiuzhang.com.cn/about/27.html) :

Jiuzhang Bio is a biotechnology company headquartered in Chengdu, China, dedicated to developing cutting-edge anti-cancer and anti-aging therapies based on chlorogenic acid (CHA). Chlorogenic acid is derived from Jiuzhang Biological proprietary technology, which is the extraction and purification of well-known Chinese herbs.

Biohealth products come in a variety of forms, including tablets, gummies and/or powders; Serum for skin care; And the best absorption effect of intravenous drip and injection.

Founded by its Chairman and CEO, Jie Zhang, Jiuzhang Bio's product was developed by its research and development team in collaboration with Professor Wenbin Li, a leading neurosurgeon and clinical research expert in China.

About Miska Bay Health Group (www.miskawaanhealth.com) :

With two locations in Bangkok and one in Koh Samui, Miska Bay Health Group Thailand provides quality medical services to local and international clients, focusing on anti-aging and anti-cancer treatments. The doctors, scientists and medical team at Miska Bay tailor effective treatments to patients and use advanced diagnostic techniques to combine natural remedies with traditional medicine to achieve the best possible outcomes.

Founded in 2018 by David Boehm, Chairman and CEO, and Dr. Johannes Wessolly, Medical Director, Miska Bay Health Group Thailand has three health centers located at the Miska Bay International Hospital under construction in Bangkok, the Miska Bay Anti-Aging Clinic at the Sukhothai Hotel in Bangkok, And a rehabilitation clinic at Miska Bay Villa on Koh Samui.



Prev:Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation